Tenax Therapeutics (TENX) Gross Margin (2011 - 2013)

Tenax Therapeutics (TENX) reported Gross Margin of 28.22% for Q2 2013, up 2265.0% on a YoY basis from 1.19% in Q2 2012, and up 4594.01% sequentially from 0.6% in Q1 2013.

Tenax Therapeutics (TENX) Gross Margin (2011 - 2013) Analysis & Trends

Tenax Therapeutics (TENX) has 3 years of Gross Margin data on file, last reported at 28.22% in Q2 2013.

  • For the quarter ending Q2 2013, Gross Margin rose 2265.0% year-over-year to 28.22%; the trailing twelve-month figure through Dec 2015 stood at 24.28% (changed N/A YoY), and the FY2014 full-year result was 39.57%, down 4391.0% from the prior year.
  • Gross Margin advanced to 28.22% in Q2 2013, from 0.6% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2011 to a low of 0.6% in Q1 2013.
  • A 3-year average of 30.08% and a median of 5.57% in 2012 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin plunged 9792 bps in 2012 and soared 2265 bps in 2013, its largest moves.
  • Tracing TENX's Gross Margin over 3 years: stood at 31.69% in 2011, then plunged by 97 bps to 1.07% in 2012, then jumped by 2544 bps to 28.22% in 2013.
  • Business Quant data shows TENX's Gross Margin at 28.22% in Q2 2013, 0.6% in Q1 2013, and 1.07% in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 88.95%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 86.85%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 91.79%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 90.68%
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Tenax Therapeutics 655.78 Mn 655.78 Mn - -

Historic Data

Download Data
DateValue
Apr 30, 2013 28.22%
Jan 31, 2013 0.60%
Oct 31, 2012 1.07%
Jul 31, 2012 2.08%
Apr 30, 2012 5.57%
Jan 31, 2012 1.48%
Oct 31, 2011 31.69%
Jul 31, 2011 100.00%
Apr 30, 2011 100.00%